Kalmegh (Andrographis)

What it is

Kalmegh (Andrographis paniculata) is a bitter medicinal herb used in Ayurveda and other Asian traditions, with limited human evidence for some infections. Its main studied compound is andrographolide, a diterpene lactone thought to contribute to anti-inflammatory and immune effects. In Ayurveda, kalmegh is commonly described as tikta (bitter) and is traditionally used for fever, digestive complaints, and some liver-related conditions. It is also used in Siddha, Unani, and traditional Chinese medicine.

The whole plant, especially the aerial parts and leaves, is used in powders, decoctions, tablets, and extracts. Commercial products vary widely, which matters because the amount of andrographolide can differ from one preparation to another. That variation is one reason why study results are not always easy to compare.

Name	Details
Botanical name	Andrographis paniculata
Common names	Kalmegh, king of bitters, bhunimba
Main studied constituent	Andrographolide
Traditional systems	Ayurveda, Siddha, Unani, traditional Chinese medicine

In India, kalmegh appears in traditional practice and in some classical and proprietary herbal formulations, but that does not mean every use has strong modern clinical proof.

How it works

Researchers have studied kalmegh for several possible actions. Laboratory and animal studies suggest that andrographolide and related compounds may affect inflammatory signaling pathways, oxidative stress, and some immune responses. Proposed mechanisms include changes in cytokine signaling, effects on NF-kB-related pathways, and possible antimicrobial or antiviral activity in preclinical models.

Traditional use and modern pharmacology overlap only partly. In Ayurveda, the herb is valued for its bitter taste and its use in conditions associated with fever, poor appetite, and digestive disturbance. Modern studies focus more on measurable biological effects such as inflammation markers, liver enzymes, and symptom duration in upper respiratory infections.

These mechanisms are still not enough to prove clinical benefit. A herb can show promising cell or animal data and still fail to help people in well-designed human trials.

Evidence and uses

The best-studied modern use of andrographis is for upper respiratory tract infections, such as common-cold-like illness. Some randomized trials and reviews suggest certain standardized andrographis extracts may modestly reduce symptom severity or duration in uncomplicated respiratory infections. However, product formulations differ, study quality is mixed, and not all trials show the same effect.

For COVID-19, evidence is not strong enough to recommend kalmegh as a proven treatment. Reviews have discussed antiviral and immunomodulatory potential, but much of that evidence is preclinical or indirect. Human evidence remains limited, and kalmegh should not replace vaccination, antiviral treatment, oxygen assessment, or clinician-guided care.

For liver health, kalmegh has a long traditional reputation, and some experimental studies suggest hepatoprotective effects. But reliable human evidence for treating liver disease is limited. It should not be used as a substitute for evaluation of hepatitis, fatty liver disease, alcohol-related liver injury, or drug-induced liver problems.

For digestive complaints and fever, traditional use is longstanding, but modern clinical evidence is weaker than for respiratory symptoms. Some people use it in multi-herb formulas, which makes it harder to know what benefit comes from kalmegh itself.

A practical way to view the evidence is:

1. Most supported: short-term use in some upper respiratory infections, using standardized extracts.
2. Possible but unproven: anti-inflammatory, liver-supportive, and immune-modulating effects.
3. Not established: treatment for serious infections, chronic liver disease, cancer, or autoimmune disease.

Safety and interactions

Kalmegh is often marketed as natural, but natural does not always mean low-risk. Short-term use appears reasonably tolerated in some studies, but side effects can occur. Reported adverse effects include stomach upset, nausea, diarrhea, headache, fatigue, rash, and altered taste. Because the herb is very bitter, gastrointestinal intolerance is not unusual.

There have also been reports of allergic reactions and concerns about liver injury with some herbal products containing andrographis, although causation can be difficult to prove because products may contain multiple ingredients or contaminants. Stop use and seek medical care if symptoms such as jaundice, dark urine, severe itching, facial swelling, wheezing, or widespread rash occur.

Potential interactions are important:

Medicine or condition	Why caution is needed
Blood thinners or antiplatelet drugs	Possible increased bleeding risk is a theoretical concern
Diabetes medicines	Blood sugar could potentially be affected
Blood pressure medicines	Additive effects are possible
Immunosuppressive therapy	Immune effects may be unpredictable
Pregnancy and breastfeeding	Safety data are insufficient; avoid unless a clinician advises otherwise
Autoimmune disease	Immune modulation may be undesirable in some cases

Do not use kalmegh to self-treat high fever, shortness of breath, jaundice, severe diarrhea, or suspected dengue, malaria, hepatitis, or bacterial infection. If you take prescription medicines, ask a clinician or pharmacist before starting it. Product quality also matters. Standardized extracts from reputable manufacturers are preferable to unlabeled powders of uncertain identity.

When to see a clinician

See a clinician if you are considering kalmegh for a condition that lasts more than a few days, keeps returning, or could be serious. This includes persistent fever, breathing difficulty, chest pain, dehydration, jaundice, unexplained weight loss, or abdominal swelling.

You should also get medical advice before using kalmegh if you are pregnant, breastfeeding, older, immunocompromised, have liver or kidney disease, or take medicines for diabetes, blood pressure, clotting, or autoimmune conditions. Children should not be given herbal products without professional guidance because dosing and safety data are limited.

If you develop a rash, swelling, severe vomiting, fainting, dark urine, or yellowing of the eyes after taking kalmegh, stop the product and seek prompt care.

Limitations and open questions

The main limitation with kalmegh research is heterogeneity. Studies use different plant parts, extraction methods, doses, treatment durations, and combinations with other herbs. That makes it hard to know which preparation works, if any, and for whom.

Evidence in humans is limited for many claimed benefits. Positive findings in laboratory studies do not prove real-world clinical benefit. Better trials are needed that clearly identify the extract, quantify andrographolide content, track side effects carefully, and compare the herb with standard care.

There are also open questions about long-term safety, liver effects, use in pregnancy, and interactions with common medicines. For now, kalmegh is best viewed as a traditional herb with some promising but incomplete modern evidence, not as a replacement for diagnosis or established treatment.